Brief: Argent Biopharma Enters Collaboration Agreement For Argent EU GMP Facility In Malta
09/04/2025 24:12
April 9 (Reuters) - Argent BioPharma Ltd RGT.AX: STRATEGIC COLLABORATION AGREEMENT FOR ARGENT EU GMP FACILITY IN MALTA STRATEGIC COLLABORATION GRANTING DAVID TRADING EXCLUSIVE RIGHTS TO OPERATE RGT'S FACILITY IN MALTA DAVID TRADING GRANTED EXCLUSIVE, IRREVOCABLE OPTION TO ACQUIRE 100% OF FACILITY COMPANY'S SHARES Further company coverage: RGT.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Executes Global Licence For Non-Core Cannabis Genetics
Brief: Argent Biopharma Files Provisional US Patent On Immune Modulation And Longevity
Australia's Argent BioPharma rises to over 1-month high on new licence agreement
Brief: Argent Biopharma Signs NLC Licence To Expand Antiviral Portfolio
Brief: Argent Biopharma Says FDA-CVM Established Inad File For Cannepil Veterinary Program